The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,000.00
Bid: 12,000.00
Ask: 12,002.00
Change: -28.00 (-0.23%)
Spread: 2.00 (0.017%)
Open: 12,052.00
High: 12,094.00
Low: 11,956.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Caution prevails in world markets ahead of Fed

Wed, 17th Mar 2021 09:40

* Investors watching for signs of faster policy
normalisation

* Fed statement due at 1800 GMT

* European shares open weaken

* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates http://tmsnrt.rs/2egbfVh

By Dhara Ranasinghe

LONDON, March 17 (Reuters) - Caution descended on markets on
Wednesday with world stocks holding below recent record highs as
investors waited to see whether the U.S. Federal Reserve would
signal a faster path toward policy normalisation than previously
expected.

The U.S. central bank ends a closely anticipated two-day
meeting later in the day, after a sharp rise in U.S. Treasury
yields this year on expectations for stronger growth and
inflation.

The Fed is expected to forecast that the U.S. economy will
grow in 2021 at the fastest rate in decades. But investors who
expect rosier projections to translate to any change in monetary
policy will probably be disappointed.

"This is one of the most important Fed meetings we've had
for some time and the impact will be felt across asset classes,"
said Seema Shah, chief strategist at Principal Global Investors.

"Markets are hoping for reassurance from the Fed that rising
bond yields are not something to worry about, and that takes a
bit of steam out of the bond market."

Before the Fed statement at 1800 GMT, calm prevailed across
world markets.

MSCI's world equity index was down 0.1%, but
keeping last month's record highs within sight.

European shares were a touch softer ,
while in Asia, an index of regional equities excluding Japan
pulled back 0.4%. Japan's Nikkei 225
closed flat.

There was some good news for AstraZeneca as
Australia's pharmaceutical regulator said the rollout of the
company's COVID-19 vaccine would continue, even though many
European nations have paused vaccinations to investigate
reported side-effects.

U.S. stock futures pointed to a flat open on Wall
Street, after the S&P 500 lost 0.16% on Tuesday.

DOVISH?

Benchmark 10-year Treasury yields were a touch
higher at 1.63%, holding near 13-month highs reached on Friday.
They have risen 72 basis points so far this year. That compares
with a 24 bps increase in German peers and a 7 bps
rise in Japanese borrowing costs.

Inflation expectations have also ticked higher with the
break-even rate on 10-year Treasury Inflation-Protected
Securities (TIPS) on Tuesday rising above 2.3% for
the first time since July 2014. The break-even rate for 30-year
TIPS hit 2.24%, the highest since September 2014.

"We expect (Fed Chair Jerome) Powell to note the FOMC has
the tools to intervene if the bond market becomes disorderly or
constrains the economic recovery," analysts at Commonwealth Bank
of Australia wrote.

"But we expect Powell to push back against talk of policy
tightening because of the large amount of labour market slack
... U.S. bond yields and the U.S. dollar could jump if the
FOMC’s post-meeting statement and Powell’s statement are not
deemed dovish enough."

An index tracking the dollar against six major peers
was around 91.92. The euro was weaker on the day at $1.1892
. The dollar was up about 0.1% at 109.13 yen.

Currency market caution may extend all week, with the Bank
of England meeting on Thursday and the Bank of Japan wrapping up
a policy review on Friday, in which it may phase out a numerical
target for its asset buying.

Elsewhere, oil prices slipped for a fourth day as concern
about weaker demand in Europe outweighed an industry report that
showed U.S. crude stockpiles unexpectedly fell last week.

Brent crude futures fell 27 cents to $68.12 a barrel
and U.S. crude futures slipped 14 cents to $64.65.

For Reuters Live Markets blog on European and UK stock
markets, please click on:

(Reporting by Dhara Ranasinghe; Additional reporting by Kevin
Buckland in Tokyo; editing by Larry King)

More News
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.